Traumatic brain injury in young, amyloid-β peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished deposition during aging

Journal of Comparative Neurology

Volumn 411, Issue 3, 1999, Pages 390-398

  Nakagawa, Yasushi ^a   Nakamura, Michio ^a   McIntosh, Tracy K ^a   Rodriguez, Amaris ^a   Berlin, Jesse A ^a   Smith, Douglas H ^a   Saatman, Kathryn E ^a   Raghupathi, Ramesh ^a   Clemens, James ^b   Saido, Takaomi C ^c   Schmidt, M Luise ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer's disease; Amyloid plaques; Head trauma; Neuron degeneration

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 0032787320     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9861(19990830)411:3<390::aid-cne3>3.0.co;2-%23     Document Type: Article

References (64)

1. Aral H, Lee VM-Y, Otvos L Jr., Greenberg B, Lowery DE, Sharma SK, Schmidt ML, Trojanowski JQ. 1990. Defined neurofilament, τ, and β-amyloid precursor protein epitopes distinguish Alzheimer from Non-Alzheimer senile plaques. Proc Natl Acad Sci USA 87:2249-2253.
2. Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C. 1998. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch G Psychol 55:225-232.
3. Buxbaum JD, Christensen JL, Ruefli AA, Greengard P, Loring JF. 1993. Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem Biophys Res Commun 197:639-645.
4. Citron M, Westaway D, Xia W, Carlson DT, Levesque G, Johnson-Wood K, Lee M, Seubert P, A. Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St. George Hyslop P, Selkoe D. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med 3:67-72.
5. Clark RSB, Chen J, Watkins SCV, Kochanek PM, Chen M, Stetler RA, Loeffert JEW, Graham SH. 1997. Apoptosis suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neurosci 17:9172-9182.
6. Colicos MA, Dixon CE, Dash PK. 1996. Delayed, selective neuronal death following experimental cortical impact injury in rats: possible role in memory deficits. Brain Res 739:111-119.
7. Conti AC, Raghupathi R, Trojanowski JQ, McIntosh T. 1998. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed posttraumatic period. J Neurosci 18:5663-5672.
8. Cummings BJ, Pike CJ, Shankle R, Cotman CW. 1996. β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging 17:921-933.
9. Dickson DW. 1997. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321-339.
10. Duff KC, Eckman C, Zehr C, Yu X, Prada C, Pereztur J, Button M, Buce L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolu L, Zenk B, Hardy J, Younkin S. 1996. Increased amyloidbeta 42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713.
11. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Giodo T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Liebergurg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Muck EL, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
12. Goedert M, Trojanowski JQ, Lee VM-Y. 1997. The neurofibrillary pathology of Alzheimer's disease. In: Prusiner SB, Rosenberg RN, Di Mauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease, 2nd ed. Boston, MA: Butterworth Heineman Press. p 613-627.
13. Greenberg BD, Savage MJ, Howland DS, Ali SM, Siedlak SL, Perry G, Siman R, Scott RW. 1996. APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol Aging 17:153-171.
14. Guillery RW, Herrup K. 1997. Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol 386:2-7.
15. Hoffman R, Lee VM-Y, Leight S, Varga I, Otvos L Jr. 1997. Unique Alzheimer's disease paired helical filament epitopes involve double phosphorylation at specific sites. Biochemistry 36:8114-8124.
16. Hsiao KK. 1997. Understanding the biology and molecular pathogenesis of Alzheimer's disease in transgenic mice expressing amyloid precursor proteins. In: Wasco W, Tanzi RE, editors. Molecular mechanisms of dementia. Totowa, NJ: Humana Press. p 39-44.
17. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
18. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. 1997a. APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965-973.
19. Irizarry MC, Soriano F, McNamara M, Page KJ, Shenk D, Games D, Hyman BT. 1997b. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the PDAPP transgenic mouse. J Neurosci 17:7053-7059.
20. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. 1994. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53.
21. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y. 1995. Amyloid Aβ protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 37:294-299.
22. Iwatsubo T, Saido T, Mann DMA, Lee VM-Y, Trojanowski JQ. 1996. Full-length Aβ (1-42(43)] as well as amino-terminally modified and truncated Aβ42(43) deposit in diffuse plaques. Am J Pathol 149:1823-1830.
23. Johnson-Wood K, Lee M, Motter R, Hu R, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberberg I, Schenk D, Seubert P, McConologue L. 1997. Amyloid precursor protein processing and Aβ42 deposition in transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 94:1550-1554.
24. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. 1997. Apolipoprotein E ∈4 allele associated with chronic traumatic brain injury in boxing. JAMA 278:136-140.
25. LeBlanc A. 1997. Apoptosis and Alzheimer's disease. In: Tanzi RE, Wasco W, editors. Molecular mechanisms of dementia. Totowa NJ: Humana Press. p 57-72.
26. Lee VM-Y, Page CD, Wu H-L, Schlaepfer WW. 1984. Monoclonal antibodies to gel-excised glial filament protein and their reactivities with other intermediate filament proteins. J Neurochem 42:25-32.
27. Lewen A, Li GL, Nilsson P, Olsson Y, Hillered L. 1995. Traumatic brain injury in rat produces changes of β-amyloid precursor protein immunoreactivity. Neurol Rep 6:357-360.
28. Loring J, Paszty C, Ross A, McIntosh TK, Murai H, Pierce JES, Trojanowski JQ, Schramm SR, Wymore K, Rubin EM, Peterson KR, Lee V M-Y. 1996. Rational design of an animal model for Alzheimer's disease: introduction of multiple human genomic transgenes to reproduce Alzheimer's disease pathology in a rodent. Neurobiol Aging 17:173-182.
29. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. 1996. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci 16:5795-5811.
30. Matsuo ES, Shin R-W, Billingsley ML, Van de Voorde A, O'Connor M, Trojanowski JQ, Lee V M-Y. 1994. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13:989-1002.
31. Maxwell WL, Povlishock JT, Graham DI. 1997. A mechanistic analysis of non-disruptive axonal injury: a review. J Neurotrauma 14:419-440.
32. Mayeux R, Ottman R, Maestre G, Ngai C, Tang M, Ginsberg H, Chun M, Tycko B, Shelanski M. 1995. Synergistic effects of traumatic head injury and apolipoprotein ∈4 in patients with Alzheimer's disease. Neurology 45:555-557.
33. Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Grain B, Tang M-X, Phelps CH, and the Alzheimer's Disease Centers Consortium on Apoliproptein E and Alzheimer's Disease. 1998. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. New Engl J Med 338:506-511.
34. McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, Lee VM-Y, Trojanowski JQ. 1998. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenic mechanisms. Neuropathol Appl Neurobiol 24:251-267.
35. Morrison-Bogorad M, Weiner MF, Rosenberg RN, Bigio E, White CL III. 1997. Alzheimer's disease. In: Prusiner SB, Rosenberg RN, Di Mauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease, 2nd ed. Boston, MA: Butterworth Heineman Press. p 581-600.
36. Mortimer JA, Van Duijn CM, Chandra L, Fratiglioni L, Graves AB, A. Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA, Shalat SL, Soininen H, Hoffman A. 1991. Head trauma as a risk factor for Alzheimer's disease: a collaborative reanalysis of case-control studies. Int J Epidemiol 20:S28-S35.
37. Murai H, Pierce JES, Raghupathi R, Smith DH, Saatman KE, Trojanowski JQ, Lee VM-Y, Loring JF, Eckman C, Younkin S, McIntosh TK. 1998. Two-fold over expression of human β-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive or neurodegenerative sequelae following experimental brain injury. J Comp Neurol 392:428-438.
38. Nicoll JAR, Roberts GW, Graham DI. 1995. Apolipoprotein E ∈4 allele is associated with deposition of amyloid β protein following head injury. Nature Med 1:135-137.
39. Pearson BE, Choi TK. 1993. Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc Natl Acad Sci USA 90:10578-10582.
40. Pierce JES, Trojanowski JQ, Graham DI, Smith DH, McIntosh TK. 1996. Immuno-histochemical characterization of alterations in the distribution of amyloid precursor proteins and β-amyloid peptide after experimental brain injury in the rat. J Neurosci 16:1083-1090.
41. Pierce JES, Smith DH, Trojanowski JQ, McIntosh TK. 1998. Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following experimental brain injury in rats. Neuroscience 87:359-369.
42. Reaume AG, Howland DS, Trusko SP, Savage MJ, Lang DM, Greenberg BD, Siman R, Scott RW. 1996. Enhanced amyloidogenic processing of the β-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a humanized Aβ sequence. J Biol Chem 271:23380-23388.
43. Rink A, Fung KM, Trojanowski JQ, Lee VM-Y, Neugebauer E, McIntosh TK. 1995. Evidence of apoptotic cell death following experimental traumatic brain injury in the rat. Am J Pathol 147:1575-1583.
44. Roberts GW, Allsop D, Bruton C. 1990. The occult aftermath of boxing. J Neurol Neurosurg Psychiatr 53:373-378.
45. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. 1994. β-Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatr 57:419-425.
46. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, Mucke L. 1995. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 47:28257-28267.
47. Saldo TC. 1998. Alzheimer's disease as proteolytic disorders: anabolism and catabolism of β-amyloid. Neurobiol Aging S69-S75.
48. Saido TC, Iwatsubo T, Mann DMA, Shimada H, Ihara Y, Kawashima S. 1995. Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques. Neuron 14:1-20.
49. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S. 1996. Amino-and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci Lett 215:173-176.
50. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull WA, Larson F, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg GD, Tanzi R, Wasco W, Lannfelt L, Selkoe DJ, Younkin S. 1996. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 2:864-870.
51. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. 1994. An extensive network of PHFτ-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett 344:69-73.
52. Schmidt ML, Lee VM-T, Saido T, Perl D, Schuck T, Iwatsubo T, Trojanowski JQ. 1998. Amyloid plaques in Guam amyotrophic lateral sclerosis/ parkinsonism-dementia complex contain species of Aβ similar to those found in the amyloid plaques of Alzheimer's disease and pathological aging. Acta Neuropathol 95:117-122.
53. Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, Sano M, Stern Y, Mayeux R. 1997. Alzheimer's disease after remote head injury: an incidence study. J Neurol Neurosurg Psychiatr 62:119-124.
54. Selkoe DJ. 1997. Cellular and molecular biology of the beta-amyloid precursor protein and Alzheimer's cisease. In: Prusiner SB, Rosenberg RN, Di Mauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease, 2nd ed. Boston, MA: Butterworth Heineman Press. p 601-612.
55. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. 1994. Markers of axonal injury in postmortem human brain. J Neuropathol 88:433-439.
56. Shin R-W, Ogino K, Kondo A, Saido T, Trojanowski JQ, Kitamoto T, Tateishi J. 1997. Amyloid β-protein (Aβ) 1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer's disease amyloid fibrils in rat brain. J Neurosci 17:8187-8193.
57. Smith DH, Soares HD, Pierce JES, Perlman KG, Saatman KE, Meaney DF, Dixon CE, McIntosh TK. 1995. A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects. J Neurotrauma 12:169-178.
58. Smith DH, Chen X-H, Pierce JES, Wolf JA, Trojanowski JQ, Graham DI, McIntosh TK. 1997. Progressive atrophy and neuronal cell death for one year following experimental brain trauma in the rat. J Neurotrauma 14:715-727.
59. Smith DH, Nakamura M, McIntosh TK, Wang J, Rodriguez A, Raghupathi R, Saatman KE, Clemens J, Schmidt ML, Lee VM-Y, Trojanowski JQ. 1998. Brain trauma induces massive hippocampal neuron death linked to a surge in Aβ1-42 levels in mice overexpressing mutant APP. Am J Pathol 153:1005-1010.
60. Sturchler-Pierrat C, Abramoski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, Ledermann B, Buerki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
61. 717) mutants. Science 264:1336-1340.
62. Teasdale GM, Nicoll JAR, Murray G, Fiddes M. 1997. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-1071.
63. Tokuda T, Ikeda S, Yanagisawa N, Ihara Y, Glenner GG. 1991. Reexamination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein. Acta Neuropathol 82:281-285.
64. Yachnis AT, Rorke LB, Lee VM-Y, Trojanowski JQ. 1993. Expression of neuronal and glial polypeptides during histogenesis of the human cerebellar cortex including observations on the dentate nucleus. J Comp Neurol 334:356-369.